N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide
C22H18ClFN6O2 — CID 162746556
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide
N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide (PubChem CID 162746556) has the molecular formula C22H18ClFN6O2 and a molecular weight of 452.88 g/mol. Its IUPAC name is N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide.
Molecular Properties
| Compound Name | N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide |
|---|---|
| PubChem CID | 162746556 |
| Molecular Formula | C22H18ClFN6O2 |
| Molecular Weight | 452.88 g/mol |
| Exact Mass | 452.12 |
| IUPAC Name | N-[2-[acetyl-(2-methylbenzotriazol-5-yl)amino]-4-pyridinyl]-2-(2-chloro-3-fluorophenyl)acetamide |
| SMILES | CC(=O)N(c1ccc2nn(C)nc2c1)c1cc(NC(=O)Cc2cccc(F)c2Cl)ccn1 |
| InChI | InChI=1S/C22H18ClFN6O2/c1-13(31)30(16-6-7-18-19(12-16)28-29(2)27-18)20-11-15(8-9-25-20)26-21(32)10-14-4-3-5-17(24)22(14)23/h3-9,11-12H,10H2,1-2H3,(H,25,26,32) |
| InChIKey | NJCVBXBLLKZYKP-UHFFFAOYSA-N |
| XLogP | 4.02 |
| TPSA | 93.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.88 |
| LogP ≤ 5 | 4.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162746556 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.